Big Biotech Reaches Important Technical Juncture

MarketsETF Trends

After notching one of its worst annual performances in recent memory last year, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets, has come roaring back in 2017 with a year-to-date gain of nearly 13%. Now the big biotechnology ETF finds itself at a critical technical point around the…Click to read more at

Continue Reading Below